Antibody-Drug Conjugate

TW202641594APending Publication Date: 2026-10-16SHANGHAI ESCUGEN BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW115100516
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-01-06
Filing Date
2026-01-06
Publication Date
2026-10-16

Smart Images

  • Figure TWG2TA001080878_001
    Figure TWG2TA001080878_001
  • Figure TWG2TA001080878_002
    Figure TWG2TA001080878_002
  • Figure TWG2TA001080878_003
    Figure TWG2TA001080878_003
Patent Text Reader

Abstract

The antibody-drug conjugate described herein has a high specific binding ability to tumor cells expressing TROP2 protein, thereby achieving excellent cell killing effect.
Need to check novelty before this filing date? Find Prior Art